文献速递前列腺癌

系统评价与Meta分析评估PSMA PET/CT在前列腺癌初始分期中的诊断准确性

A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-05-31

该系统评价与Meta分析检索截至2023年3月的Medline、Scopus和Web of Science数据库,纳入49项研究共3876例患者,评估PSMA PET/CT对比常规影像在前列腺癌初始分期中的诊断准确性。仅精囊腺侵犯和淋巴结侵犯检测可行Meta分析,前者汇总敏感度42.29%、特异度87.59%,后者汇总敏感度43.63%、特异度85.55%。作者指出PSMA PET-CT在检测精囊腺侵犯方面有效、在淋巴结侵犯方面准确性良好,但临床T分期、前列腺外侵犯和远处转移评估缺乏高质量研究,需进一步严谨研究。

要点

  • PSMA PET/CT检测精囊腺侵犯汇总敏感度42.29%、特异度87.59%、PPV 93.39%、NPV 86.60%。
  • PSMA PET/CT检测淋巴结侵犯汇总敏感度43.63%、特异度85.55%、PPV 67.47%、NPV 83.61%。
  • 临床T分期、前列腺外侵犯和远处转移评估缺乏高质量研究,作者强调需进一步严谨研究。

核心结论

  • 本系统评价与Meta分析显示PSMA PET-CT在检测精囊腺侵犯方面有效,在淋巴结侵犯检测方面对比常规影像准确性良好。
  • 该分析也揭示其在临床T分期、前列腺外侵犯和远处转移评估方面缺乏高质量研究,作者强调需进一步严谨研究。

研究设计与样本

  • 系统评价与Meta分析,检索Medline、Scopus和Web of Science数据库截至2023年3月,遵循PRISMA指南筛选合格研究。
  • 共纳入49项研究、3876例患者,其中6项研究评估PSMA PET/CT检测精囊腺侵犯的准确性。
  • 18项研究评估PSMA PET/CT检测淋巴结侵犯的准确性;因数据不可得,Meta分析仅对精囊腺侵犯和淋巴结侵犯检测可行。

主要发现

  • 检测精囊腺侵犯:汇总敏感度42.29%(95%CI:29.85-55.78%)、特异度87.59%(95%CI:77.10%-93.67%)、PPV 93.39%(95%CI:74.95%-98.52%)、NPV 86.60%(95%CI:58.83%-96.69%);异质性分析显示PPV和NPV存在显著变异。
  • 检测淋巴结侵犯:汇总敏感度43.63%(95%CI:34.19-53.56%)、特异度85.55%(95%CI:75.95%-91.74%)、PPV 67.47%(95%CI:52.42%-79.6%)、NPV 83.61%(95%CI:79.19%-87.24%);研究间未发现显著异质性。

关键数值与推荐

  • 精囊腺侵犯检测:汇总敏感度42.29%(95%CI:29.85-55.78%)、特异度87.59%(95%CI:77.10%-93.67%)、PPV 93.39%(95%CI:74.95%-98.52%)、NPV 86.60%(95%CI:58.83%-96.69%)。
  • 淋巴结侵犯检测:汇总敏感度43.63%(95%CI:34.19-53.56%)、特异度85.55%(95%CI:75.95%-91.74%)、PPV 67.47%(95%CI:52.42%-79.6%)、NPV 83.61%(95%CI:79.19%-87.24%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出因数据不可得,Meta分析仅对精囊腺侵犯和淋巴结侵犯检测可行。
  • 原文指出精囊腺侵犯检测的PPV和NPV存在显著异质性变异。
  • 原文指出临床T分期、前列腺外侵犯和远处转移评估缺乏高质量研究。
  • 原文强调需进一步严谨研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Positron Emission Tomography-Computed Tomography using Prostate-Specific Membrane Antigen (PSMA PET/CT) is notable for its superior sensitivity and specificity in detecting recurrent PCa and is under investigation for its potential in pre-treatment staging. Despite its established efficacy in nodal and metastasis staging in trial setting, its role in primary staging awaits fuller validation due to limited evidence on oncologic outcomes. This systematic review and meta-analysis aims to appraise the diagnostic accuracy of PSMA PET/CT compared to CI for comprehensive PCa staging. METHODS: Medline, Scopus and Web of science databases were searched till March 2023. Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines were followed to identify eligible studies. Primary outcomes were specificity, sensitivity, positive predictive value (PPV) and negative predictive value (NPV) of PSMA PET/CT for local, nodal and metastatic staging in PCa patients. Due to the unavailability of data, a meta-analysis was feasible only for detection of seminal vesicles invasion (SVI) and LNI. RESULTS: A total of 49 studies, comprising 3876 patients, were included. Of these, 6 investigated accuracy of PSMA PET/CT in detection of SVI. Pooled sensitivity, specificity, PPV and NPV were 42.29% (95%CI: 29.85-55.78%), 87.59% (95%CI: 77.10%-93.67%), 93.39% (95%CI: 74.95%-98.52%) and 86.60% (95%CI: 58.83%-96.69%), respectively. Heterogeneity analysis revealed significant variability for PPV and NPV. 18 studies investigated PSMA PET/CT accuracy in detection of LNI. Aggregate sensitivity, specificity, PPV and NPV were 43.63% (95%CI: 34.19-53.56%), 85.55% (95%CI: 75.95%-91.74%), 67.47% (95%CI: 52.42%-79.6%) and 83.61% (95%CI: 79.19%-87.24%). No significant heterogeneity was found between studies. CONCLUSIONS: The present systematic review and meta-analysis highlights PSMA PET-CT effectiveness in detecting SVI and its good accuracy in LNI compared to CI. Nonetheless, it also reveals a lack of high-quality research on its performance in clinical T staging, extraprostatic extension and distant metastasis evaluation, emphasizing the need for further rigorous studies.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Mari A, Cadenar A, Giudici S, et al. A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer. Prostate Cancer Prostatic Dis. 2024. PMID: 38822051. doi:10.1038/s41391-024-00850-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。